More on ARMP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.07 |
|
|||
| Open | $4.07 | ||||
| 52 Wk High | $2.00 | ||||
| 52 Wk Low | $1.50 | ||||
| Day High | $4.07 | ||||
| Day Low | $4.07 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,941 | ||||
- Form 8-K Armata Pharmaceuticals, For: Sep 14
- FDA grants Armata Pharmaceuticals breakthrough therapy status for AP-SA02
- Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
- Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Armata Pharmaceuticals publishes phage biology study in molecular journal
- Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials
- Armata Pharmaceuticals, Inc. (ARMP) Tops Q2 EPS by 17c
- Form 10-Q Armata Pharmaceuticals, For: Jun 30
- Form 8-K Armata Pharmaceuticals, For: Aug 12
- Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
Entities mentioned with ARMP
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13D | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- Show More...
